Inflammatory breast cancer (IBC) is an aggressive breast cancer that develops rapidly and often does not present as a lump, making it harder to spot on a mammogram. Instead, people notice symptoms such as a rash or swelling, which can easily be confused with a breast infection. IBC can progress rapidly and is often at […]
Susan G. Komen® hosted the Metastatic Breast Cancer (MBC) Collaborative Research Summit on October 13, 2022, in Durham, North Carolina.
Leading Breast Cancer Experts from Duke Cancer Institute and UNC Lineberger Comprehensive Cancer Center Give Scientific Presentations Susan G. Komen®, the world’s leading breast cancer organization, will be gathering renowned experts and researchers focused on metastatic breast cancer (MBC) at the annual Metastatic Breast Cancer Collaborative Research (MBCCRI) Summit on Thursday, October 13, 2022. Experts will […]
Komen-funded researcher Dr. Amelie Ramirez is seeking to improve long-term outcomes for Hispanic and Latina breast cancer survivors through a holistic program.
Komen-funded researcher Dr. Pedram Ravazi is leading a three-part study to identify microscopic breast cancer metastases in patients so it can be treated before it becomes deadly.
Dr. Neil Vasan is a Komen grantee and recounts some amazing opportunities and discoveries during the COIVD-19 pandemic.
Susan G. Komen®, the world’s leading breast cancer organization, is awarding $21.7 million to fund 48 new research projects at 26 distinguished academic medical institutions in the U.S. that are focused on improving patient outcomes – particularly for people with the most aggressive breast cancers, or who have experienced a recurrence or metastasis. With this […]
As a 41-year-old mother of two, Eli Levene had just started a new job as the executive director of a North Carolina-based childhood education nonprofit in 2016 when she went for her routine mammogram.
A fortuitous finding led to Leigh Pate being diagnosed with lobular breast cancer and her eventual advocacy for the cause.
The only thing that is certain is that I will eventually need a third and a fourth treatment, and then I’ll need a therapy that doesn’t even exist yet. That’s why research is so important. It is what gives all of us living with MBC hope. We know it is research that will prolong our lives.
Together: Finding the Cures Metastatic Breast Cancer Collaborative Research Initiative Susan G. Komen + Duke University + University of North Carolina at Chapel Hill = REAL IMPACT Our Partners The Metastatic Breast Cancer Collaborative Research Initiative is dedicated to funding research breakthroughs specifically for metastatic breast cancer in the labs of two of the most renowned research […]
The Susan G. Komen Metastatic Breast Cancer Collaborative Research Virtual Summit will be held Feb. 19, 2021